CRSP Jan 2026 40.000 call
| Previous close | 28.80 |
| Open | 28.00 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 40.00 |
| Expiry date | 2026-01-16 |
| Day's range | 28.00 - 28.80 |
| Contract range | N/A |
| Volume | |
| Open interest | 67 |
ZacksWhy Is CRISPR Therapeutics (CRSP) Up 12% Since Last Earnings Report?
CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksCRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It
CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Globe NewswireCRISPR Therapeutics to Participate in Upcoming Investor Conferences
ZUG, Switzerland and BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the following investor conferences in June. Jefferies Healthcare ConferenceDate: Wednesday, June 5, 2024Time: 10:00 a.m. ET Goldman Sach’s 45th Annual Global Healthcare ConferenceDate: Tuesday, June 11, 20
